Role of monomeric amyloid-β in cognitive performance in Alzheimer's disease: Insights from clinical trials with secretase inhibitors and monoclonal antibodies
Bruno Pietro Imbimbo, Stefania Ippati, Mark Watling, Camillo Imbimbo
The abstract is not reproduced here because its license does not permit redistribution. Read it at the original source.
Record
- Archive ID
- doi:10.1016/j.phrs.2022.106631
- Published
- Dec 28, 2022
- Venue
- Pharmacological Research
- DOI
- 10.1016/j.phrs.2022.106631
- PubMed
- 36586644
- Categories
- Alzheimer's disease research and treatments
- License
- cc-by-nc-nd
- Provenance
- openalex